, a pharmaceutical startup backed by Durham, N.C.-based Intersouth Partners, has pulled plans for an initial public offering of stock.

Alimera, which is focused on ophthalmic drugs, had hoped to raise $75 million. Alimera filed for the IPO last summer.

The company withdrew the IPO citing “current public market conditions” as the cause. Alimera wanted to go public on the Nasdaq and was being advised by Credit Suisse as well as Citi.

Intersouth owns some 18 percent of Alimera, which launched in 2004.

Alimera raised $30 million in 2008 and more than $70 million in all closed on since launch.